clinical study retractions – Page 19

Journal expresses a great deal of concern over deceased author’s work

A gastroenterology journal has issued an extensive expression of concern about a 2013 paper by Yoshihiro Sato, a Japanese endocrinologist who has posthumously been climbing the Retraction Watch leaderboard. (He’s now ranked number three, ahead of Diederik Stapel.)

To call the statement an “expression of concern” is like calling Charles M. Schulz a talented cartoonist, or Escoffier a pretty good cook. Indeed, the journal expresses so much concern, about, well, so much, that we’re not sure what in the paper would be left unscathed.

Sato, formerly of Hirosaki University, currently has 77 retractions for a range of misconduct-related issues including likely data fabrication and duplication.

Cancer specialists in Mexico earn third retraction following questions about their data

Cases of cancers seen at the Instituto Mexicano del Seguro Social, according to researcher Agustin Avilés

A group of cancer researchers in Mexico has lost their third paper over concerns about the integrity of their data.

Neither the new retraction, in the journal Hematology, nor the previous two, cite misconduct as the reason for the removals. However, the statements do refer to lack of reliability of results, “ambiguities and inconsistencies” in the findings and other serious issues.

The first author on each paper is Agustin Avilés, whom the Hematology article listed as being with the National Medical Center in Mexico City.

According to the retraction notice:

Stanford calling for retractions of work by deceased star cancer researcher

The Journal of Clinical Investigation has retracted two papers from the lab of one of Stanford University’s most prominent cancer researchers over concerns about the integrity of the data.

The articles, published in 2012 and 2014, described work on ways of priming the immune system to enhance the activity of drugs to fight cancer.

The first author on the two articles was Holbrook “Brook” Kohrt, a superstar young faculty member who died in 2016 of complications of hemophilia. Kohrt was the subject of this 2013 profile in the New York Times, which also wrote an obituary of him.

Catholic medical journal pulls paper on conversion therapy over statistical problems

The journal for a religious medical group is retracting a paper that supported the discredited practice of conversion therapy for homosexuals over concerns about the statistical analyses — or lack thereof — in the research.

The paper, “Effects of therapy on religious men who have unwanted same-sex attraction,” was published last year in The Linacre Quarterly, the official journal of the Catholic Medical Association. (According to its website: “LQR explores issues at the interface of medicine and religion, focusing on bioethics and also exploring medical topics which have an ethical dimension.)

So, what were those effects? Pretty darn good, according to the article. Per the abstract:

CrossFit demands retraction of paper claiming their participants are more likely to be injured

Saying that a paper has “fatal and disqualifying errors,” CrossFit is demanding the retraction of a recently published article that claimed those participating in CrossFit “are more likely to be injured and to seek medical treatment compared with participants in traditional weightlifting.”

The paper, “Likelihood of Injury and Medical Care Between CrossFit and Traditional Weightlifting Participants,” was published on May 7 in the Orthopaedic Journal of Sports Medicine.

In a May 17 letter to the journal’s editor and the paper’s corresponding author, CrossFit general counsel Marshall Brenner said the article

Too much skin in the game: Derm journal calls out author for duplication

We often praise authors for doing the right thing by retracting with transparency. Here’s a journal that deserves recognition for its handling of a case of duplicate publication.

Acta Dermatovenerologica Alpina, Pannonica et Adriatica (ADAPA), a European derm publication, has retracted a 2018 article in smack-down fashion, calling out a co-author for deceit. The paper was a case study titled “Inflamed bilateral linear atrophoderma of Moulin in an adult woman: a case report.” According to ADAPA, a reader noticed that a virtually identical article — with the same title — had appeared in a Turkish dermatology publication in late 2017.

In an lengthy editorial, Jovan Miljković, the editor-in-chief of the journal, explained what happened after a review of the two papers found them to be “virtually identical”: Continue reading Too much skin in the game: Derm journal calls out author for duplication

Carlo Croce loses a round in legal bid to be reinstated as dep’t chair

Carlo Croce, a professor at The Ohio State University in Columbus who has faced multiple investigations into misconduct allegations, has been denied a temporary restraining order that he sought in order to be reinstated as chair of his department.

Croce was forced to step down from the post last year. Magistrate Jennifer D. Hunt, of the Franklin County civil court, wrote in a January 23 decision that

third parties and the public interest will be harmed if a temporary restraining order is granted and Dr. Croce is reinstated as Chair.

Croce, OSU said Continue reading Carlo Croce loses a round in legal bid to be reinstated as dep’t chair

“This is something that we have never seen before in any study:” Group loses two more papers

A group of rheumatology researchers in Egypt that lost a paper in 2016 for a variety of problems has lost two more.

The authors common to the two papers, Anna Abou-Raya and Suzan Abou-Raya, are based at the University of Alexandria, which did not find evidence of scientific misconduct, according to one of the retraction notices. The journal that published the two papers, The Journal of Rheumatology, however, found several other issues that led them to retract the papers.

Among them was that for one of the studies to have proceeded as described, all 125 subjects would have had to been enrolled and randomized on a single day: Continue reading “This is something that we have never seen before in any study:” Group loses two more papers

OSU cancer researcher who has faced misconduct allegations sues to regain lost department chairmanship

Carlo Croce, the embattled cancer researcher at The Ohio State University (OSU), is suing the institution to reclaim the department chair he lost late last year for reasons that he says are unclear.

In a filing with the Franklin County civil court, Croce and his attorneys, from the Columbus firm of James E. Arnold and Associates, argue that the university failed to follow its own rules for demoting faculty members last year when it stripped Croce of his position of chair of the Department of Cancer Genetics and Biology. Croce had held the post for more than three consecutive four-year terms, starting in October 2004.

The nut of Croce’s claim centers on the alleged failure of K. Craig Kent, the university’s Dean of the College of Medicine, to consult with the college’s faculty members before demoting him in early November 2018 — a move Croce opposed. Continue reading OSU cancer researcher who has faced misconduct allegations sues to regain lost department chairmanship

Anversa cardiac stem cell lab earns 13 retractions

Two months after Harvard and the Brigham and Women’s Hospital said they were requesting the retraction of more than 30 papers from a former cardiac stem cell lab there, two American Heart Association journals have retracted more than a dozen papers from the lab.

Yesterday, Circulation retracted three papers, and Circulation Research retracted 10. All 13 were among 15 subjected to expressions of concern last month. Continue reading Anversa cardiac stem cell lab earns 13 retractions

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: